In patients with COVID-19, virus-specific CD4+ and CD8+ T cell response (with SARS-CoV-2-conserved T cell epitopes detected in the S1-spike/RBD proteins) has been seen in patients with less severe illness, possibly reflecting cellular immunity suppressing SARS-CoV-2-associated disease [26,27,28]. This evidence concerns the gene CD8A and COVID-19.